Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
56%
Total
Publications
153
Total Open
Publications
85
Total
Citations
7.1K
Open Access
Percentage
56%
Total
Publications
153
Total Open
Publications
85
Total
Citations
7.1K
Breakdown
Publisher Open
16%
Both
26%
Other Platform Open
13%
Closed
45%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
23
Hybrid 32%
20
No Guarantees 32%
20
Other Platform Open
Domain 67%
42
Other Internet 38%
24
Institution 14%
9
Preprint 5%
3
Public 5%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 42 |
DOI | Other Internet | 24 |
Europe PMC | Domain | 9 |
Office of Scientific and Technical Information | Institution | 4 |
Figshare | Public | 3 |
epfl.ch OAI-PMH Repository | Institution | 2 |
bioRxiv | Preprint | 2 |
Washington University in St. Louis | Institution | 1 |
UNSW Sydney | Institution | 1 |
University of Southern Denmark | Institution | 1 |